https://www.selleckchem.com/pr....oducts/cucurbitacin-
Future research is needed to establish optimal anticoagulation and blood transfusion management. Compared with the 2013 pediatric population, extracorporeal membrane oxygenation center anticoagulation and blood transfusion approaches continue to vary widely. Most report continued use of heparin as their primary anticoagulant and follow a combination of monitoring assays with the majority using the antifactor Xa assay in their practices, a significant shift from prior results. Antithrombin activity levels and viscoelastic tests ar
Like
Comment
Share
